Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review

Hepatitis B virus (HBV) infection is regarded as the main etiological risk factor in the process of hepatocellular carcinoma (HCC), as it promotes an immunosuppressive microenvironment that is partially mediated by the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) signalin...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Bin Li, Cong Yan, Jiamin Zhu, Xiaobing Chen, Qihan Fu, Hangyu Zhang, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao, Weiqin Jiang, Weijia Fang
التنسيق: Artigo
اللغة:Inglês
منشور في: Frontiers Media S.A. 2020-05-01
سلاسل:Frontiers in Immunology
الموضوعات:
immunotherapy
hepatocellular carcinoma
hepatitis B virus
programmed cell death protein 1
programmed death-ligand 1
tumor microenvironment
الوصول للمادة أونلاين:https://www.frontiersin.org/article/10.3389/fimmu.2020.01037/full
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة